Suchergebnisse - "Scalise, Carly"

PubPharm (17)

1

Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies

enthalten in: Gynecologic oncology | 2024

von Recio, F. | Scalise, C. | Loar, P. | +14

2

Endogenous pAKT activity is associated with response to AKT inhibition alone and in combination with immune checkpoint inhibition in murine models of TNBC

enthalten in: Cancer letters | 2024

von Bullock, K. | Shattuck-Brandt, R. | Scalise, C. | +9

3

A spatial proteomic study of platinum refractory HGSOC implicates dual AKT and WNT activity linked to an immunosuppressive tumor microenvironment

enthalten in: Gynecologic oncology | 2024

von Scalise, C. | Kincaid, K. | Thigpen, H. | +8

4

Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors

enthalten in: Molecular oncology | 2023

von Kalashnikova, E. | Aushev, V. | Malashevich, A. | +16

5

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

enthalten in: Frontiers in oncology | 2023

von Lebow, E. | Shaverdian, N. | Eichholz, J. | +29

6

Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment

enthalten in: Seminars in cancer biology | 2022

von Monavarian, M. | Elhaw, A. | Tang, P. | +8

7

Metabolic Alterations and WNT Signaling Impact Immune Response in HGSOC

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Arend, R. | Scalise, C. | Gordon, E. | +5

8

High-intermediate risk endometrial cancer : moving toward a molecularly based risk assessment profile

enthalten in: International journal of clinical oncology | 2022

von Kako, T. | Kamal, M. | Dholakia, J. | +2

9

High-intermediate risk endometrial cancer: moving toward a molecularly based risk assessment profile

enthalten in: International journal of clinical oncology | 2022

von Kako, T. | Kamal, M. | Dholakia, J. | +2

10

High-intermediate risk endometrial cancer: moving toward a molecularly based risk assessment profile

enthalten in: International journal of clinical oncology | 2022

von Kako, T. | Kamal, M. | Dholakia, J. | +2